LMATLeMaitre Vascular, Inc.

$2B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$38M+5.4% YoY

Gross Profit

$25M64.8% margin

Operating Income

$9M23.6% margin

Net Income

$7M17.0% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

-5.7%

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$12M

Stock-Based Comp.

$797,000

Balance Sheet

Total Assets

$289M

Total Liabilities

$40M

Stockholders' Equity

$249M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$36M	+5.4%
Gross Profit	$25M	$23M	+9.5%
Operating Income	$9M	$10M	-9.4%
Net Income	$7M	$8M	-13.4%

Geographic Segments

Americas

$25M66%

EMEA

$11M27%

Asia Pacific

$3M7%

LMAT Q3 2021 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena